Clinical Trial: Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC
Study Status: Completed
Recruit Status: RECRUITING
Condition: Breast Cancer Recurrent
Study Type: INTERVENTIONAL
Official Title: Towards Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of Triple Negative Breast Cancer
Brief Summary:
This is a prospective phase 2 study to use Functional Precision Oncology (FPO) to predict, prevent and treat early metastatic recurrence in subjects with HR-low/Her2 negative or triple negative breast cancer.
Read more